| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/22/2004 | US20040014111 Methods for the identification of IKKalpha function and other genes useful for treatment of imflammatory diseases |
| 01/22/2004 | US20040014057 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/22/2004 | US20040014038 G-protein coupled receptor (GPCR) polypeptides, vectors, host cells, antibodies, and recombinant methods for producing nucleic acids/polypeptides; methods for diagnosis, treatment, and prevention of disorders involving these human proteins |
| 01/22/2004 | US20040013727 Hydrophilic gel foaming matrix; cellulose ethers |
| 01/22/2004 | US20040013720 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 01/22/2004 | US20040013718 Three-dimensional body; antiinflammatory agents, autoimmune diseases; in situ response; side effect reduction |
| 01/22/2004 | US20040013708 Mixture containing emulsifiers, proteins and lipophilic starch; food processing |
| 01/22/2004 | US20040013676 Administering dosage of mature dendritic cells in carrier |
| 01/22/2004 | US20040013656 Fermentation soybean milk |
| 01/22/2004 | US20040013645 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/22/2004 | CA2843044A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid |
| 01/22/2004 | CA2833808A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 01/22/2004 | CA2494245A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | CA2493374A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/22/2004 | CA2493373A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | CA2493004A1 Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | CA2492781A1 Medicinal composition for mitigating blood lipid or lowering blood homocystein |
| 01/22/2004 | CA2492722A1 Production method of coated preparations |
| 01/22/2004 | CA2492720A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid |
| 01/22/2004 | CA2492669A1 Novel indoline compound and medicinal use thereof |
| 01/22/2004 | CA2492561A1 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | CA2492430A1 Phenylalanine enamide derivatives |
| 01/22/2004 | CA2492427A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 01/22/2004 | CA2492421A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 01/22/2004 | CA2492381A1 Phenylalanine enamide derivatives containing a spiro[3.5]non-1-ene ring for use as integrin inhibitors |
| 01/22/2004 | CA2492374A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 01/22/2004 | CA2492330A1 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 01/22/2004 | CA2492164A1 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | CA2492046A1 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 01/22/2004 | CA2492045A1 Substituted amine derivatives and methods of use |
| 01/22/2004 | CA2491183A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/22/2004 | CA2490818A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/22/2004 | CA2489084A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 01/21/2004 | EP1382662A1 Sterol compositions, fat compositions containing the same and foods |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382605A2 8-azabicyclo(3.2.1)oct-2-ene derivatives and their use as nAChR ligands |
| 01/21/2004 | EP1382604A1 Quinoline derivative having azolyl group and quinazoline derivative |
| 01/21/2004 | EP1382603A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF |
| 01/21/2004 | EP1382339A1 Compositions containing pyrrolo [2,3-d] pyrimidine derivatives |
| 01/21/2004 | EP1382337A1 Novel formulation containing paroxetine |
| 01/21/2004 | EP1382336A1 Abc expression promoters |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1382332A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381681A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/21/2004 | EP1381630A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381615A2 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- 1,4]DIOXINO 2,3-e]INDOLE |
| 01/21/2004 | EP1381614A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO 2,3-f]QUINOXALINE |
| 01/21/2004 | EP1381613A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- 1,4]-benzodioxans |
| 01/21/2004 | EP1381607A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1381594A1 Urea compounds useful as anti-inflammatory agents |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381408A2 Modular infusion device and method |
| 01/21/2004 | EP1381385A1 Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability |
| 01/21/2004 | EP1381382A2 Methods and compositions for the treatment of diseases of the eye |
| 01/21/2004 | EP1381376A2 In vivo use of water absorbent polymers |
| 01/21/2004 | EP1381373A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method |
| 01/21/2004 | EP1381371A2 Hormone replacement therapy |
| 01/21/2004 | EP1381365A1 Pyrrolidine sulfonamides |
| 01/21/2004 | EP1381361A1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 01/21/2004 | EP1381360A1 Compounds and methods for inhibiting metap2 in mammals |
| 01/21/2004 | EP1280799B1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/21/2004 | EP1126852B1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 01/21/2004 | EP1011702A4 A method for treating diabetes, hyperglycemia and hypoglycemia |
| 01/21/2004 | CN1469876A Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469873A Piperidine compounds as anti-allergic |
| 01/21/2004 | CN1469872A A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 01/21/2004 | CN1469867A Novel phenylalanine derivatives |
| 01/21/2004 | CN1469863A Crystal form of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl] piperazine hydrochloride |
| 01/21/2004 | CN1469751A Medicinal compositions for promoting recovery from stress loading and novel matsutake mushroom strain |
| 01/21/2004 | CN1469750A Bone metabolism improving agent |
| 01/21/2004 | CN1469745A Preventives and remedies for complications of diabetes |
| 01/21/2004 | CN1469743A 雌激素受体调节剂 Estrogen receptor modulators |
| 01/21/2004 | CN1469740A Composition for improving lipid metabolism |
| 01/21/2004 | CN1468867A Soluble high branched glucose polymer and its producing process |
| 01/21/2004 | CN1468627A Oral liquid for lowering blood pressure and blood fat, preventing and treating blood vascular disease and paralysis |
| 01/21/2004 | CN1468624A Health food of haw extractive and its application |
| 01/21/2004 | CN1468607A Recipe of diabetes treating medicine |
| 01/21/2004 | CN1468603A Prepn of potassium magnesium aspartate for injection |
| 01/21/2004 | CN1468552A Slimming rice tea producing process |
| 01/21/2004 | CN1468536A Blood pressure and blood fat lowering herbal food |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/21/2004 | CN1135234C Phytostrin and/or phytosteroidal alkanol derivative |
| 01/21/2004 | CN1135224C Benzimidazole derivatives |
| 01/21/2004 | CN1135223C Aryl-substd propanolamine derivate medicine containing them and their use |
| 01/21/2004 | CN1135109C Method for producing alfalfa superfine powder |
| 01/20/2004 | US6680341 Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor |
| 01/20/2004 | US6680333 Imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2004 | US6680328 Cholinergic ligands of nicotinic acetyl choline receptors for treatment of central nervous system disorders, smooth muscle contraction disorders, endocrine diseases/disorders, neurodegeneration, inflammation, pain, and drug withdrawal |
| 01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
| 01/20/2004 | US6680310 Methods for preventing antipsychotic-induced weight gain |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680075 Natural tea for curing men's impotence and a method for manufacturing the same |
| 01/20/2004 | CA2303498C Dioxocyclopentyl hydroxamic acids |
| 01/20/2004 | CA2258501C Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 01/20/2004 | CA2243404C Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |